Compound isolated from Torilidis fructus, and anticancer pharmaceutical composition containing same as active ingredient
AssigneesPharma-Gene Co., Ltd., J-Medizin Co.,Ltd
InventorsYoung-Min Kim, Hae-Kyung Suh
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound isolated from Torilidis Fructus, and an anticancer pharmaceutical composition containing same as an active ingredient, wherein the compound of the present invention has effects of reducing the viability of various types of cancer cells, having no effect on the cell viability of normal cells and reducing the tumor size and weight of lung cancer and colorectal cancer when used in an animal model. Therefore, the compound according to the present invention can be usefully used in anticancer drugs or health functional food industries.
Claims7
A compound represented by the following Formula 1 or a pharmaceutically acceptable salt thereof
An anticancer pharmaceutical composition comprising a torilin derivative compound represented by the following Formula 1 or Formula 2, or a pharmaceutically acceptable salt thereof, as an active ingredient
An anticancer health functional food composition comprising a torilin derivative compound represented by the following Formula 1 or Formula 2, or a food acceptable salt thereof, as an active ingredient
Dependencies are inferred from the claim text.